DiCE Places Bets On Tomorrow's Small Molecules

 
• By Emily Hayes
  
Kevin Judice, CEO DiCE Molecules.
Kevin Judice, CEO of DiCE Molecules
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business